The Diabetes Channel

Disappointing Setback for Inhaled Diabetes Drug

The first inhaled insulin product, Exubera, has been discontinued due to dosing issues and pulmonary lung function test concerns.

References and Resources

Drug to be Discontinued; Exubera (insulin recombinant human, powder for inhalation).

Click Here to view the discontinuation list from the FDA.

More in Diabetes

► 06:22

Endocrinology & Metabolism Institute Diabesity Innovations

Diabetes

Bartolome Burguera, MD, PhD, describes the Endocrinology and Metabolism Institute, which is part of Cleveland Clinic. This multidisciplinary institute includes more than 50 medical and surgical endocrine specialists, pituitary specialists,...

► 09:17

Doctor Explains 13 Skin Signs of Diabetes – Never Ignore These Symptoms

Diabetes

This informative video, hosted by Khalid, a family doctor based in London, uncovers 13 skin conditions linked to diabetes, emphasizing the skin's role as a diagnostic window to internal health...

► 37:28

Update: Clinical Practice Guideline on the Management of Hyperglycemia in Hospitalized Patients

Diabetes

At the ENDO 2022 press conference, the clinical practice guideline on management of hyperglycemia in hospitalized patients in non-critical care settings was presented by Mary Korytkowski, MD, University of Pittsburgh,...

► 02:06

Pancreatic Transplants: A Cure for Diabetes?

Diabetes

Tambi Jarmi, MD, nephrologist in the Gary and Dianne McCalla Center for Transplantation and Regenerative Care at Mayo Clinic, discusses the use of early pancreas transplantation to cure diabetes. Because...